BCL2L13 Gene
protein-coding GIFtS: 54
GCID: GC22P018111
|
|
BCL2-like 13 (apoptosis facilitator)
| |
Aliases for BCL2L13 gene
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc,
7Ensembl,
8DME,
9miRBase,
and/or 10fRNAdb) About This Section
|
| Aliases |
|---|
| BCL2-Like 13 (Apoptosis Facilitator)1 2 | | Bcl-2-Like Protein 132 | | MIL11 2 3 | | Bcl-Rambo1 | | BCL-RAMBO1 2 | | Protein Mil13 | | Bcl2-L-132 3 | | |
Export aliases for BCL2L13 gene to outside databasesPrevious GC identifers: GC22P015052 GC22P016486 GC22P016496 GC22P001936 |
Summaries for BCL2L13 gene(According to Entrez Gene,
Tocris Bioscience,
Wikipedia's
Gene Wiki,
PharmGKB,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| Entrez Gene summary for BCL2L13: This gene encodes a mitochondrially-localized protein with conserved B-cell lymphoma 2 homology motifs. Overexpressionof the encoded protein results in apoptosis. Alternatively spliced transcript variants have been observed for thisgene. (provided by RefSeq, Jul 2012) UniProtKB/Swiss-Prot: B2L13_HUMAN, Q9BXK5Function: May promote the activation of caspase-3 and apoptosis Gene Wiki entry for BCL2L13
|
Genomic Views for BCL2L13 gene
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to
UCSC (hg19) and
Ensembl (release 69),
Regulatory elements and Epigenetics data according to
QIAGEN,
SABiosciences, and/or
SwitchGear Genomics) About This Section
| RefSeq DNA sequence:- NC_000022.10 NC_018933.1 NT_011519.10
Regulatory elements: SABiosciences Regulatory transcription factor binding sites in the BCL2L13 gene promoter: AhR NF-YA Egr-1 Arnt NF-YB CBF-A CBF-B CP1A NF-Y CBF(2) Other transcription factors
Search SABiosciences Chromatin IP Primers for BCL2L13
Epigenetics:
|  | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat BCL2L13 |
Genomic Location: Genomic View: UCSC Golden Path with GeneCards custom track
Entrez Gene cytogenetic band: 22q11.1 Ensembl cytogenetic band: 22q11.21 HGNC cytogenetic band: 22q11BCL2L13 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)

GeneLoc information about chromosome 22 GeneLoc Exon Structure GeneLoc location for GC22P018111: view genomic region
(about GC identifiers)
Start:
|
18,111,621 bp from pter |
End:
|
18,213,388 bp from pter |
Size:
|
101,768 bases |
Orientation:
|
plus strand |
|
Proteins for BCL2L13 gene
(According to
1UniProtKB,
HORDE,
neXtProt,
Ensembl,
and/or Reactome,
Modification sites according to 2PhosphoSitePlus,
Specific Peptides from DME,
Protein expression images according to data from SPIRE MOPED and PaxDb,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from
EMD Millipore,
R&D Systems,
GenScript,
Enzo Life Sciences,
OriGene,
Novus Biologicals,
Sino Biological,
ProSpec, and/or
Uscn,
Biochemical Assays by
EMD Millipore,
R&D Systems,
OriGene,
GenScript,
Cell Signaling Technology,
Enzo Life Sciences, and/or
Uscn,
Ontologies according to Gene
Ontology Consortium 01 Mar 2013 and
Entrez Gene,
Antibodies by
EMD Millipore,
R&D Systems,
GenScript,
Cell Signaling Technology,
OriGene,
Novus Biologicals,
Thermo Fisher Scientific,
Abcam, and/or
Uscn)
About This Section
| UniProtKB/Swiss-Prot: B2L13_HUMAN, Q9BXK5 (See
protein sequence)Recommended Name: Bcl-2-like protein 13 Size: 485 amino acids; 52723 Da
Subunit: Monomer (Probable)
Subcellular location: Isoform 2: Mitochondrion membrane; Single-pass membrane protein (Potential). Nucleus (Probable)
Subcellular location: Isoform 1: Nucleus (Probable)
Sequence caution: Sequence=AAF03602.1; Type=Erroneous initiation; Sequence=AAG09680.1; Type=Frameshift;Positions=Several;
1 PDB 3D structure from and Proteopedia for BCL2L13:2IPD (3D)
 
Secondary accessions: Q96B37 Q96IB7 Q9BY01 Q9HC05 Q9UFE0 Q9UKN3Alternative splicing: 2 isoforms: Q9BXK5-1 Q9BXK5-2 Explore the universe of human proteins at neXtProt for BCL2L13: NX_Q9BXK5
Post-translational modifications:
View modification sites using PhosphoSitePlus2View neXtProt modification sites for NX_Q9BXK5 BCL2L13 Protein expression data from MOPED and PaxDb: About this image 
REFSEQ proteins (11 alternative transcripts):
NP_001257655.1 NP_001257656.1 NP_001257657.1 NP_001257658.1 NP_001257659.1 NP_001257660.1 NP_001257661.1 NP_001257662.1 NP_001257663.1 NP_001257664.1 NP_056182.2 ENSEMBL proteins: ENSP00000382682 ENSP00000318883 ENSP00000436321 ENSP00000434764 ENSP00000347133 ENSP00000382677 ENSP00000410019 ENSP00000441344 ENSP00000437667 ENSP00000338932 Human Recombinant Protein Products:
Gene Ontology (GO): 4 cellular component terms (GO ID links to tree view): About this table
BCL2L13 for ontologies About GeneDecksing
BCL2L13 Antibody Products: Assay Products for BCL2L13: |
Protein
Domains / Families for BCL2L13 gene(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
|
BCL2L13 for domains About GeneDecksing
2 InterPro domains/families:Graphical View of Domain Structure for InterPro Entry Q9BXK5ProtoNet protein and cluster: Q9BXK5 2 Blocks protein families: IPB000712 Apoptosis regulator Bcl-2 protein IPB003093 Apoptosis regulator Bcl-2 protein
UniProtKB/Swiss-Prot: B2L13_HUMAN, Q9BXK5Similarity: Belongs to the Bcl-2 family |
Function for BCL2L13 gene
(According to 1UniProtKB,
Genatlas,
LifeMap Discovery™,
IUBMB, and/or
2DME,
Human phenotypes from GenomeRNAi,
Animal models from MGI Mar 06 2013,
bound targets from SABiosciences,
miRNA Gene Targets from miRTarBase
shRNA from
OriGene,
RNAi from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
microRNA from QIAGEN,
Gene Editing from DNA2.0,
Clones from EMD Millipore,
OriGene,
SwitchGear Genomics,
GenScript,
Sino Biological,
DNA2.0,
and Vector BioLabs,
Cell Lines from GenScript,
LifeMap BioReagents,
In Situ Hybridization Assays from Advanced Cell Diagnostics,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene.)
About This Section
| Function Summary: UniProtKB/Swiss-Prot: B2L13_HUMAN, Q9BXK5Function: May promote the activation of caspase-3 and apoptosis
Clone Products: |  | Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore | |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for BCL2L13 (see all 3) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for BCL2L13 (see all 2) OriGene custom cloning services – gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector: BCL2L13 (NM_015367) | |  | Browse Sino Biological Human cDNA Clones | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for BCL2L13 | |  | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat BCL2L13  |
In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for BCL2L13 |
Gene Ontology (GO): 1 molecular function term (GO ID links to tree view): About this table | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process |
NAS | 11262395 |
BCL2L13 for ontologies About GeneDecksing
1 GenomeRNAi human phenotype for BCL2L13:
|
Pathways & Interactions for BCL2L13 gene
(Pathways according to
EMD Millipore,
R&D Systems,
Cell Signaling Technology,
KEGG,
PharmGKB,
BioSystems,
Reactome,
Tocris Bioscience,
GeneGo (Thomson Reuters),
QIAGEN,
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Interaction Networks according to
SABiosciences,
and/or STRING,
Interactions according to 1UniProtKB,
2MINT,
3I2D, and/or
4STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Mar 2013 via
Entrez Gene).
About This Section
|
Interactions:
SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for BCL2L13
STRING Interaction
Network Preview (showing 2 interactants - click image to see more details)
 4 Interacting proteins for BCL2L13 (Q9BXK52, 3 ENSP000003188834) via UniProtKB, MINT, STRING, and/or I2DAbout this table
Gene Ontology (GO): 3 biological process terms (GO ID links to tree view): About this table | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0006917 | induction of apoptosis |
NAS | 11262395 | | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
NAS | 11262395 | | GO:0042981 | regulation of apoptotic process |
-- | -- |
BCL2L13 for ontologies About GeneDecksing
|
Drugs & Compounds for BCL2L13 gene(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
EMD Millipore, Tocris Bioscience
HMDB,
BitterDB, and/or
Novoseek, and Drugs according to
DrugBank,
Enzo Life Sciences, and/or
PharmGKB, with drugs/clinical trials/news
search links to CenterWatch)
About This Section
|
Browse Tocris compounds for BCL2L13 Search CenterWatch for drugs/clinical trials and news about BCL2L13 / B2L13 
|
Transcripts for BCL2L13 gene(Secondary structures according to
fRNAdb,
GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 235 Homo sapiens; Mar 10 2013) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
transcript ids from Ensembl
with links to UCSC,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from
EMD Millipore,
siRNAs from
OriGene,
QIAGEN,
shRNA from
OriGene,
microRNA from QIAGEN,
Tagged/untagged cDNA clones from
OriGene,
SwitchGear Genomics,
GenScript,
DNA2.0,
Vector BioLabs,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN
) About This Section
| REFSEQ mRNAs for BCL2L13 gene (11 alternative transcripts): NM_001270726.1 NM_001270727.1 NM_001270728.1 NM_001270729.1 NM_001270730.1 NM_001270731.1 NM_001270732.1 NM_001270733.1 NM_001270734.1 NM_001270735.1 NM_015367.3 Unigene Cluster for BCL2L13: BCL2-like 13 (apoptosis facilitator) Hs.631672 [show with all ESTs]Unigene Representative Sequence: NM_01536714 Ensembl transcripts including schematic representations, and UCSC links where relevant: ENST00000399781 ENST00000399782(uc002zmu.3) ENST00000317582 ENST00000498133 ENST00000464649 ENST00000493680 ENST00000355028(uc002zmw.3 uc002zmx.3 uc002zmy.3 uc010gqy.3 uc011agk.2 uc010gqz.3 uc002zmz.3 uc002zna.3) ENST00000399777 ENST00000479296 ENST00000485631 ENST00000418951 ENST00000538149 ENST00000543133 ENST00000337612
Clone Products: |  | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for BCL2L13 (see all 3) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for BCL2L13 (see all 2) OriGene custom cloning services – gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling 
| |  | GenScript: all cDNA clones in your preferred vector: BCL2L13 (NM_015367) | |  | DNA2.0 Custom Codon Optimized Gene
Synthesis Service for BCL2L13 | |  | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat BCL2L13  |
Additional cDNA sequence: AF086412.1 AF146568.1 AF246665.1 AF325209.1 AF539453.1 AK027443.1 AK056248.1 AK075044.1 AK291449.1 AK294286.1 AK301394.1 AK314489.1 AL133029.1 AL831982.2 BC003032.1 BC007658.2 BC016037.1 CR456521.1 NR_073068.1 NR_073069.1 24/35 DOTS entries (see all 35): DT.116941 DT.100060839 DT.100036828 DT.100060841 DT.100661063 DT.120653579 DT.100882422 DT.120653493 DT.95262744 DT.120653518 DT.97848973 DT.100882415 DT.92055018 DT.100882414 DT.402888 DT.100882417 DT.100882427 DT.120653520 DT.120653572 DT.100882426 DT.120653494 DT.120653501 DT.92409517 DT.100705108 24/393 AceView cDNA sequences (see all 393): BE293272 BQ720818 BM726667 BM761914 BM672198 BM687928 AI364348 BM767112 BQ049592 BM910427 BM767486 BU730017 BQ958582 AI566619 NM_015367 BU179480 CA446170 AI831026 AA928129 BU155651 AA037409 BX402374 AA226881 BG034549 GeneLoc Exon Structure
5/17 Alternative Splicing Database (ASD) splice patterns (SP) for BCL2L13 (see all 17) About this scheme
| ExUns: | 1 | ^ | 2a | · | 2b | ^ | 3a | · | 3b | · | 3c | · | 3d | · | 3e | ^ | 4 | ^ | 5a | · | 5b | · | 5c | ^ | 6 | ^ | 7a | · | 7b | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11a | · | 11b | ^ | 12a | · | 12b | ^ | 13 | ^ | 14a | · | 14b | · | 14c | · | |
| SP1: | |   | |   | |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | - |   | |   | |   | - |   | |   | |   | |   | - |   | - |   | - |   | - |   | |   | |   | |   | |
| SP2: | |   | |   | |   | - |   | - |   | - |   | - |   | - |   | - |   | |   | |   | |   | - |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | - |   | |   | |   | - |   | - |   | |   | |   | - |   | - |   | - |   | - |   | |   | |   | |   | |
| SP4: | |   | |   | |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | - |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | |   | |   | |   | |   | |   | |   | - |   | - |   | - |   | - |   | - |   | |   | |   | - |   | |   | |   | |   | - |   | - |   | - |   | - |   | |   | |   | |   |
| ExUns: | 14d | · | 14e | · | 14f | · | 14g | · | 14h | · | 14i | |
| SP1: | |   | |   | |   | |   | |   | |   | |
| SP2: | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | |   | |   | |   | |   |
ECgene alternative splicing isoforms for BCL2L13
|
Expression for BCL2L13 gene
(RNA expression data according to
H-InvDB,
NONCODE,
miRBase, and
RNAdb,
Expression images according to data from
BioGPS,
Illumina Human BodyMap, and
CGAP
SAGE,
Sets of similar genes according to GeneDecks,
in vivo and in vitro expression data from LifeMap Discovery™,
plus additional links to
Genevestigator, and/or
SOURCE, and/or
BioGPS, and/or
UniProtKB,
PCR Arrays from
SABiosciences,
Primers from
OriGene,
SABiosciences, and/or
QIAGEN,
In Situ Hybridization Assays from Advanced Cell Diagnostics)
About This Section
| BCL2L13 expression in normal human tissues (normalized intensities) See probesets specificity/sensitivity at GeneAnnot About this imageBioGPS CGAP TAG: CCCGAGGGCC
About this image See BCL2L13 Protein Expression from SPIRE MOPED and PaxDB Genevestigator expression for BCL2L13
SOURCE GeneReport for Unigene cluster: Hs.631672 UniProtKB/Swiss-Prot: B2L13_HUMAN, Q9BXK5Tissue specificity: Ubiquitous, with the highest levels of expression in heart, placenta and pancreas SABiosciences Expression via Pathway-Focused PCR Array including BCL2L13:
Primer Products: |  | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for BCL2L13 Browse OriGene validated miRNA SYBR primer pairs
| |  | SABiosciences RT2 qPCR Primer Assay in human, mouse, rat BCL2L13 | |  | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat BCL2L13 | |  | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat BCL2L13 | In Situ Assay Products: |
| Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for BCL2L13 |
Orthologs for BCL2L13 gene
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
,
5MGI Mar 06 2013,
with possible further links to
Flybase
and/or
WormBase,
and/or
6Ensembl pan taxonomic compara ,
Gene Trees according to Ensembl and
TreeFam)
About This Section
|
This gene was present in the common ancestor of chordates.
Orthologs for BCL2L13 gene from 5/11 species (see all 11) About this table
| Organism |
Taxonomic classification |
Gene |
Description |
Human Similarity |
Orthology Type |
Details |
mouse (Mus musculus) |
Mammalia |
Bcl2l131 , 5 |
BCL2-like 13 (apoptosis facilitator)1, 5 |
79.72(n)1 76.73(a)1 |
  |
6 (57.01 cM)5 940441 NM_153516.21 NP_705736.11 1208362305 |
chicken (Gallus gallus) |
Aves |
BCL2L131 |
BCL2-like 13 (apoptosis facilitator) |
69.31(n) 71.67(a) |
  |
418163 XM_416394.3 XP_416394.1 |
lizard (Anolis carolinensis) |
Reptilia |
BCL2L136 |
-- |
72(a) |
1 ↔ 1 |
5(14030460-14054437) |
tropical clawed frog (Xenopus tropicalis) |
Amphibia |
Str.9492 |
Transcribed sequence with weak similarity to protein more |
76.54(n) |
  |
AL970202.2 |
zebrafish (Danio rerio) |
Actinopterygii |
bcl2l131 |
BCL2-like 13 (apoptosis facilitator) |
53.63(n) 50.44(a) |
  |
559355 NM_001044891.2 NP_001038356.1 |
ENSEMBL Gene Tree for BCL2L13 (if available) TreeFam Gene Tree for BCL2L13 (if available)  |
Paralogs for BCL2L13 gene(Paralogs according to
1HomoloGene, 2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68) About This Section
| -- |
Genomic Variants for BCL2L13 gene(SNPs/Variants according to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE,
UniProtKB, and
DNA2.0,
Linkage Disequilibrium by HapMap,
Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene
Mutation Database (HGMD) and the Locus Specific Mutation
Databases (LSDB), Blood group antigen gene mutations by BGMUT,
Resequencing Primers from QIAGEN,
Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
About This Section
|
| Genomic Data | Transcription Related Data | Allele Frequencies | | SNP ID | Valid | Clinical significance | Chr 22 pos | Sequence | # | AA Chg | Type | More | # | Allele freq | Pop | Total sample | More |
|---|
HapMap Linkage Disequilibrium report for BCL2L13 (18111621 - 18213388 bp)
Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions) Database of Genomic Variants (DGV): 6 variations for BCL2L13 4 CNVs: 67830 79424 90862 67829 2 Indels: 79423 79425  | SABiosciences Cancer Mutation PCR Assays |
|  | QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing BCL2L13 |
|
Disorders
/ Diseases for BCL2L13 gene
(in which this Gene is Involved, According to MalaCards,
OMIM, UniProtKB,
the University of Copenhagen DISEASES
database,
Genatlas, GeneTests,
GAD,
HuGE Navigator,
and/or TGDB.)
About This Section
|
BCL2L13 for disorders About GeneDecksing
16 diseases for BCL2L13: About MalaCardsb-cell lymphomas cat eye syndrome non-hodgkin lymphoma hodgkin's lymphoma acute lymphoblastic leukemia lymphoblastic leukemia cowpox hepatitis b leukemia hepatitis prostatitis churg-strauss syndrome leukemia/lymphoma, t-cell leukemia/lymphoma liposarcoma breast cancer Human Genome Epidemiology (HuGE) Navigator: BCL2L13 (6 documents) Export disorders for BCL2L13 gene to outside databases
|
Publications for BCL2L13 gene (in
PubMed.
Associations of this gene to articles via
1Entrez Gene,
2UniProtKB/Swiss-Prot,
3HGNC,
4GAD,
5PharmGKB,
6HMDB,
7DrugBank,
8UniProtKB/TrEMBL,
9 Novoseek, and/or
10fRNAdb)
About This Section
|
PubMed articles for BCL2L13 gene, integrated from 9 sources (see all 36): (articles sorted by number of sources associating them with BCL2L13) | |  | Utopia: connect your pdf to the dynamic world of online information |
- Analysis of the cat eye syndrome critical region in humans and the region of conserved synteny in mice: a search for candidate genes at or near the human chromosome 22 pericentromere. (PubMed id 11381032)1, 2, 3 Footz T.K....McDermid H.E. (2001)
- Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. (PubMed id 11262395)1, 2, 3 Kataoka T....Tschopp J. (2001)
- A quantitative atlas of mitotic phosphorylation. (PubMed id 18669648)1, 2 Dephoure N.... Gygi S.P. (2008)
- The full-ORF clone resource of the German cDNA consortium. (PubMed id 17974005)1, 2 Bechtel S.... Schupp I. (2007)
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)1, 2 Gerhard D.S....Malek J. (2004)
- A genome annotation-driven approach to cloning the human ORFeome. (PubMed id 15461802)1, 2 Collins J.E.... Dunham I. (2004)
- The DNA sequence of human chromosome 22. (PubMed id 10591208)1, 2 Dunham I....O'Brien K.P. (1999)
- Bcl-rambo induces apoptosis via interaction with the a denine nucleotide translocator. (PubMed id 22921587)1 Kim J.Y....Park J.H. (2012)
- Initial characterization of the human central proteome. (PubMed id 21269460)2 Burkard T.R.... Colinge J. (2011)
- A proteome-wide, quantitative survey of in vivo ubiqui tylation sites reveals widespread regulatory roles. (PubMed id 21890473)1 Wagner S.A....Choudhary C. (2011)
|
External Searches for BCL2L13 gene
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing BCL2L13 gene
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
Kegg,
and/or
H-InvDB)
About This Section
|
|
Other Databases showing BCL2L13 gene
(According to HUGE)
About This Section
| -- |
Specialized Databases showing BCL2L13 gene(According to PharmGKB,
ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| PharmGKB entry for BCL2L13 | Pharmacogenomics, SNPs, Pathways |
|
| | |
About This Section
| Patent Information for BCL2L13 gene: Search GeneIP for patents involving BCL2L13
GeneCards and IP: Japan Patent Office Licenses GeneCards European Patent Office Licenses GeneCards Improving the IP Search
|
Products for BCL2L13 gene(Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Uscn, Thermo Fisher Scientific, Gene Editing from DNA2.0, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Cell lines from GenScript and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or
Enzo Life Sciences), In Situ Hybridization Assays from Advanced Cell Diagnostics About This Section
|
 | |
 | |
 |
| | | | OriGene Antibodies for BCL2L13 | | OriGene shRNA RFP for BCL2L13 | | OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for BCL2L13 | | OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for BCL2L13 | | OriGene Protein Over-expression Lysate for BCL2L13 | | Browse OriGene Fluorogenic Cell Assay Kits | | OriGene siRNA for BCL2L13 | | OriGene 3'-UTR Clone for BCL2L13 | | OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for BCL2L13 | | OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for BCL2L13 | | Browse OriGene GFP tagged cDNA clones in CMV expression vector | | Browse OriGene MicroRNA Expression Plasmids | | Browse OriGene basic RS shRNAs | | Browse OriGene validated miRNA SYBR primer pairs | | OriGene Purified Protein for BCL2L13 | | OriGene custom cloning services - gene synthesis, subcloning, mutagenesis,
variant library, vector shuttling | | OriGene Custom Antibody Services for BCL2L13 | | OriGene Custom Protein Services for BCL2L13 | | OriGene Custom Immunoassay Development | | |
| |  |
 |
| | QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat BCL2L13 | | QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing BCL2L13 | | QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat BCL2L13 | | QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat BCL2L13 | | QIAGEN QuantiFast Probe-based Assays in human, mouse, rat BCL2L13 | | QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat BCL2L13 |
| |
 |  |  |  | |
| | | Search Tocris compounds for BCL2L13 |
| |  |  |  |  | | | | |
 |
 |
 |
 | | BCL2L13 Proteins, Antibodies, CLIAs, and ELISAs |
| | | | Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for BCL2L13 |
|  |  |  | | | ThermoFisher Antibodies for BCL2L13 |
| | Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat BCL2L13 |
|
|
|
|